Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.
------------------------------------------------------------
October 4, 2002
U.S. IMMUNIZATION NEWS
"Ebola Vaccine Will Enter Human Trials Within Months"
Reuters Health Information Services (www.reutershealth.com) (10/03/02); Ault, Alicia
The director of the National Institute of Allergy and Infectious Diseases (NIAID), Dr. Anthony Fauci, announced Thursday that a vaccine against the Ebola virus will begin human clinical trials within the next six months to eight months. The focus on bioterrorism and financing of such projects has allowed researchers to speed up the development process of a vaccine against the disease, Fauci said at a meeting of the World Medical Association in Washington. NIAID is providing the Dutch biotechnology company Crucell with Ebola genes used in the vaccine, with the company retaining the exclusive right to sell the completed vaccine.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.